Here are four quick facts:
1. The company’s total short interest reached 337,000 shares in February.
2. During the last trading session, Amedica’s shares increased 10.68 percent.
3. Since July 17, 2015, the shares have declined nearly 73 percent.
4. Amedica’s shares have underperformed the S&P 500 by 64.34 percent.
More articles on devices:
26 spine devices receive FDA 510(k) clearance in January
Medtronic, Stryker, Zimmer Biomet, DePuy Synthes, Smith & Nephew: Who had the best 2015? 32 things to know
Cervical artificial disc replacement & lateral spine surgery: 6 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.